Previous Meetings

GBCC 2017

Global Breast Cancer Conference 2017

07:30-08:10
Satellite Symposium 5
Venue: Halla Hall
  • Enhancing Endocrine Therapy for Hormone Receptor-positive Advanced Breast Cancer
    Sung-Bae Kim (ASAN Medical Center, Korea)
08:00-09:30
Practicing Breast Surgeons Session
Current Issues in Breast Clinic
Venue: Weolla Room
  • Role of KABTS in the Management of Breast Cancer in Korea
    Tae Ik Eom (Hiu Breast & Thyroid Clinic, Korea)
  • Role of Ultrasound in Breast Cancer Screening
    Dongwon Kim (Daerim St. Mary's Hospital, Korea)
  • BIRADS Categorization in Practice: Under or Over-categorization of Breast Lesions
    Hyewon Ro (Honest U Surgery Clinic, Korea)
  • VABB in Breast Clinic
    Kyung Ho Cha (Mamma Breast Clinic, Korea)
  • Current Issues in Breast Clinic
    Junho Kim (Dr. Kim Breast Thyroid Clinic, Korea)
08:30-09:30
Plenary Lecture 5
Venue: Halla Hall
  • Haute Couture Tailoring of Radiation Therapy in Breast Cancer
    Philip Poortmans (Institut Curie Paris, France)
09:40-10:50
Symposium 5
To Treat or Not
Venue: Halla Hall
  • Post-BCS WBRT: Invasive Carcinoma & DCIS
    Su Ssan Kim (Univ. of Ulsan College of Medicine, ASAN Medical Center, Korea)
  • PMRT in pN1
    Hae Jin Park (Hanyang Univ. Hospital, Korea)
  • IMN: Balancing Risks and Benefits
    Philip Poortmans (Institut Curie Paris, France)
Survivorship Session
Advances in Breast Cancer Survivor's Care
Venue: Lotus Hall
  • Breast Cancer Survivorship Research and Care Practices from a Japanese Perspective
    Miyako Takahashi (National Cancer Center, Japan)
  • Life after Breast Cancer in Australia
    Hyukjai Shin (Myongji Hospital, Medical School of Seonam Univ., Korea)
  • Health Status and Healthcare Utilization of Breast Cancer Survivors
    Jihyoun Lee (Soonchunhyang Univ. Hospital Seoul, Korea)
Oral Presentation 2
Venue: Weolla Room
  • GENETIC DETERMINANTS OF SPORADIC BREAST CANCER IN A COHORT OF SRI LANKAN POSTMENOPAUSAL WOMEN
    Nirmala Sirisena (Univ. of Colombo, Sri Lanka)
  • LUMINAL ANDROGEN RECEPTOR AND ANDROGEN RECEPTOR-HIGH TRIPLE-NEGATIVE BREAST CANCERS ARE GENETICALLY SIMILAR TO LUMINAL BREAST CANCERS
    Jisun Kim (ASAN Medical Center, Korea)
  • CIRCULATING TUMOR DNA PRESENTS VARIABLE CLONAL RESPONSE OF BREAST CANCER DURING NEOADJUVANT CHEMOTX
    Ji-Yeon Kim (Samsung Medical Center (Samsung Seoul Hospital), Korea)
  • PREDICTIVE ROLE OF FCRR3A-158 POLYMORPHISM AND STROMAL TUMOR INFILTRATING LYMPHOCYTES IN PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER
    Heejung Chae (ASAN Medical Center, Korea)
  • PHASE II STUDY OF APATINIB PLUS VINORELBINE, A NOVEL COMBINATION OF ALL-ORAL REGIMEN IN HEAVILY PRETREATED PATIENTS WITH METASTATIC HER2-NEGATIVE BREAST CANCER
    Anjie Zhu (Chinese Academy of Medical Science Pumc, China)
  • BREAST CANCER TRENDS IN YOUNG WOMEN - A SINGAPOREAN PERSPECTIVE
    Yirong Sim (Singhealth Duke-nus Breast Centre, Singapore)
  • RISK STRATIFICATION WITH ENDOPREDICT SIGNATURE FOR LUMINAL SUBTYPE BREAST CANCERS: RE-ANALYZING MICROARRAY EXPERIMENTS WITH HAN CHINESE ORIGIN
    Chi-Cheng Huang (Cathay General Hospital, Taiwan)
  • INTRODUCING THE JAPANESE BREAST CANCER REGISTRY AND THE ACTIVITY
    Naoki Hayashi (St. Luke's International Hospital, Japan)
10:50-12:00
Symposium 6
Personalized Therapy
Venue: Halla Hall
  • How to Interpret the Omics Big Data and Apply to the Clinical Practice
    Yu Shyr (Vanderbilt Univ. Medical Center, U.S.A.)
  • Personalized Adjuvant Therapy Based on Clinical Trials in Breast Cancer: Dream or Reality?
    Martine Piccart (Institut Jules Bordet, Belgium)
  • Where Are We Now, to the Precision Medicine
    Masakazu Toi (Kyoto Univ. Hospital, Japan)
Education Session 3
Cell Cycle, CDKs and Breast Cancer: A Changing Paradigm
Venue: Lotus Hall
  • Cell Cycle Regulation and Targeting CDK 4/6 for Treatment of Breast Cancer
    Seock-Ah Im (Seoul National Univ., Korea)
  • CDK 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Clinical Data
    Jin-Hee Ahn (ASAN Medical Center, Korea)
  • Ongoing Clinical Trials Combining CDK 4/6 Inhibitors and Related Biomarkers
    Soohyeon Lee (Pfizer Oncology, Korea)
Oral Presentation 3
Venue: Weolla Room
  • EXOSOMAL DEL-1 AS A POTENT DIAGNOSTIC MARKER FOR BREAST CANCER: A PROSPECTIVE COHORT STUDY
    Soo Jung Lee (Kyungpook National Univ. School of Medicine, Korea)
  • A SINGLE CENTER STUDY OF RISK REDUCING MANAGEMENT IN BRCA MUTATION CARRIERS AFTER DIAGNOSIS OF BREAST CANCER
    Hyokjo Kang (National Cancer Center, Korea)
  • DNA METHYLATION PATTERNS OF CANCER TISSUES ASSOCIATED WITH BREAST CANCER SURVIVAL
    Choonghyun Ahn (Seoul National Univ. College of Medicine, Korea)
  • MYBL1 REARRANGEMENTS AND MYB AMPLIFICATION IN BREAST ADENOID CYSTIC CARCINOMA LACKING THE MYB-NFIB FUSION GENE
    Jisun Kim (ASAN Medical Center, Korea)
  • PREDICOTRS FOR COSMETIC OUTCOME IN ONCOPLASTIC MASTOPEXY TECHNIQUES
    Chin-Yau Chen (National Yang-ming Univ. Hospital, Taiwan)
  • RANDOMIZED PHASE 2, OPEN-LABEL, DOSE-RANGING STUDY OF A NOVEL, LONG-ACTING G-CSF, EFLAPEGRASTIM (SPI-2012, ROLONTISTM) OR PEGFILGRASTIM FOR THE MANAGEMENT OF NEUTROPENIA IN PATIENTS WITH BREAST CANCER
    Gajanan Bhat (Spectrum Pharmaceuticals, U.S.A.)
  • WNT-DP103-GSK3β CASCADE PROMOTES WNT/β-CATENIN SIGNALING IN PARENTAL AND STEM CELLS FROM TRIPLE NEGATIVE BREAST CANCER
    Alan Prem Kumar (National Univ. of Singapore, Singapore)
Back to Previous Meetings